Harold Bays

1998–2025 年に発表

139
論文数
25,927
被引用数
84
h 指数
134
i10 指数

被引用数

Harold Bays の年別被引用数1969 年: 被引用 1 件1976 年: 被引用 2 件1997 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 4 件2002 年: 被引用 14 件2003 年: 被引用 54 件2004 年: 被引用 79 件2005 年: 被引用 103 件2006 年: 被引用 111 件2007 年: 被引用 109 件2008 年: 被引用 166 件2009 年: 被引用 123 件2010 年: 被引用 113 件2011 年: 被引用 165 件2012 年: 被引用 127 件2013 年: 被引用 174 件2014 年: 被引用 185 件2015 年: 被引用 206 件2016 年: 被引用 245 件2017 年: 被引用 230 件2018 年: 被引用 208 件2019 年: 被引用 592 件2020 年: 被引用 646 件2021 年: 被引用 664 件2022 年: 被引用 744 件2023 年: 被引用 815 件2024 年: 被引用 1,270 件2025 年: 被引用 1,019 件2026 年: 被引用 48 件1970〜1975 年は被引用が無いため表示していません1977〜1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,609 件、この内訳の 26%イギリス: 引用元論文 727 件、この内訳の 7.2%中国: 引用元論文 646 件、この内訳の 6.4%イタリア: 引用元論文 569 件、この内訳の 5.7%カナダ: 引用元論文 452 件、この内訳の 4.5%ドイツ: 引用元論文 399 件、この内訳の 4%オーストラリア: 引用元論文 358 件、この内訳の 3.6%フランス: 引用元論文 257 件、この内訳の 2.6%オランダ: 引用元論文 254 件、この内訳の 2.5%デンマーク: 引用元論文 244 件、この内訳の 2.4%スペイン: 引用元論文 224 件、この内訳の 2.2%インド: 引用元論文 198 件、この内訳の 2%
0%26%その他 30.9%

分野

  • Medicine78.7%
  • Biochemistry, Genetics and Molecular Biology8.4%
  • Nursing4.3%
  • Neuroscience2.2%
  • Health Professions1.5%
  • Immunology and Microbiology0.9%
  • その他4%

トピック

  • Lipoproteins and Cardiovascular Health9.4%
  • Diabetes Treatment and Management7.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6.1%
  • Pharmacology and Obesity Treatment4.3%
  • Diet and metabolism studies3.1%
  • Bariatric Surgery and Outcomes2.9%
  • その他67.1%

共著者

全論文

検索で開く
  1. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mariana P. Monteiro, Dírcea Rodrigues, Aysha Badat, P Joshi, Gulam Latiff, Essack Mitha, Hans H. Snyman, Elane van Nieuwenhuizen, Olga González Albarrán, Assumpta Caixàs, Carmen de al Cuesta, Pedro Pablo García‐Luna, Cristobal Morales Portillo, Pedro Mezquita Raya, Miguel A. Rubio, Niclas Abrahamsson, Johan Hoffstedt, Fredrik von Wowern, Erik Uddman, Birgit Bach-Kliegel, Felix Beuschlein, Stefan Bilz, Alain Golay, Gottfried Rudofsky, Christopher Strey, G. D. Fadieienko, Н. В. Косей, Т. Ф Татарчук, V. I. Velychko, Olesya Zinych, Stephen Aronoff, Harold Bays, Andrew Brockmyre, Robert S. Call, Charles H. Crump, Cyrus Desouza, Valerie Espinosa, Almena Free, Winston H. Gandy, S Geller, Gregory Gottschlich, Frank L. Greenway, Laurie J. Han-Conrad, Wayne L. Harper, Lee Herman, Mitzie Hewitt, Priscilla Hollander, S. Kaster, Anastasios Manessis, Frederick A. Martin, Robert E. McNeill, Alexander V. Murray, Paul Norwood, John C.H. Reed, Julio Rosenstock, Domenica Rubino, Martin Schear, Mark Warren - JAMA 2021 被引用: 1,242

  2. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi‐Ching Yang, Wen-Yuan Lin, Chien‐Ning Huang, Kuo‐Chin Huang, David Fitz-Patrick, Cindy HT Pau, Phillip D. Toth, G.H. Freeman, Donald F Gardner, Alan Wynne, Juan Loy, Deborah B. Horn, Purvi Mehra, Stacey Layle, James H. Bergthold, José de Souza, Venkatesh Nadar, G Angulo, Ken Cohen, Timothy R. Smith, Louis J. Aronne, Michael G. Vaughn, Altagracia Aurora Alcantara-Gonzalez, Seth Forman, John Agaiby, S Geller, Neil J. Fraser, Robert A. Jenders, Kim Barbel-Johnson, Ronald K. Mayfield, Carl D Vance, Kevin T Prier, Alexander V. Murray, Michael Lillestol, Douglas Denham, Jean Park, E. Klein, Harold Bays, Athena Philis‐Tsimikas, Peter E Bressler, John C.H. Reed, Shamaila Aslam, Julio Rosenstock, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Martha Gomez-Cuellar, Lisa Connery, Joanna Van, Jean-Louis Sélam, John Kim, Dwight Blake, John Gabriel, Samir Arora, Michael J McCartney, Royce Keith Solano, Steven K Brodie, John Nardandrea - JAMA 2023 被引用: 709

  3. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 875

  4. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Ortiz, Enrique Villegas, Albina Golovach, Diana Alpenidze, Elena Frolova, Elena Zhdanova, Ludmila Ruyatkina, О. Б. Ершова, Ю. Г. Самойлова, S. T. Zyangirova, Katarina Lalić, Nebojša Lalić, Teodora Beljić Živković, Hayriye Esra Ataoğlu, Okan Bakıner, A. D. Dayan, Mehmet Sargın, Meral Mert, Mine Adaş, Ömür Tabak, Yüksel Altuntaş, Alexander V. Murray, Ali Iranmanesh, Aron Schlau, Bram Wieskopf, Brian D. Snyder, Carl J. Griffin, Charles Fogarty, Charles Lovell, Dale Allison, David Fitzpatrick, David Grant, David C. Klonoff, Dwayne Williams, Eddie Armas, Eileen M. Palace, Gary Ruoff, Gilbert Martinez, Gilberto Perez, Harold Bays, Horia Tatu, James Maynard, Jeanne-Elyse Cedeno, Vanita R. Aroda, Jean Park, Jennefer Sutton, Joe Pouzar, John Bertsch, Jonathan Condit, Jorge Serje, Josel Cabaccan, Joseph Risser, Juan P. Frías, Julio Rosenstock, Kanagaratnam Sivalingam, Kelli Maw, Lenita Hanson, Liana K. Billings, Lisa Connery, Mario Juarez, Michael Lillestol, Neil Fraser, Paul Beckett, Ralph Wade, Raul Gaona, Richard F. W. Jackson, Robert DeLuca, Sady Alpizar, Sharon J. Herring, Stanley Stringam ほか 5 名 - Diabetes Care 2019 被引用: 468

  5. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

    著者: , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 326

  6. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

    著者: , , , , , , , - New England Journal of Medicine 2019 被引用: 796

  7. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation

    著者: , , , , , , , , , , - European Journal of Preventive Cardiology 2022 被引用: 334

  8. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

    著者: , , , , , , , , , - European Journal of Preventive Cardiology 2019 被引用: 360

  9. Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Pawel Bogdanski, Douglas Friars, Robert Schlosser, Boguslaw Okopien, Madhusudan Budhraja, Lawrence Feld, Leslie Klaff, Guy Tellier, Giuseppe Mazza, Iwona Wierzbicka, Ewa Jazwinska-Tarnawska, Fernando Boccalandro, Julio Rosenstock, Elizabeth Marquez, Kim Barbel-Johnson, Katarzyna Madziarska, Kenneth Heaton, Jean-Claude Tardif, John Rubino, Miguel Trevino, Katie Moriarty, Anil Gupta, Wojciech Wojakowski, James Fidelholtz, Dinesh Gupta, Hani Alasaad, Shane Christensen, Parag Shah, Stephanie Li, Mark Sherman, Andre Frechette, Cecilia Arango, Alan Egan, Sunny Srivastava, Archna Bajaj, Carlos Ince Jr, Aleksander Zurakowski - Circulation 2022 被引用: 202

  10. The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

    著者: , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 101

  11. Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , I N El Ebrashy, Mohamed Hesham Mohamed Fahmy El Hefnawy, Freddy G. Eliaschewitz, MATTHEW FINNERAN, Stefan Fischli, Evelyn Fließer-Görzer, Jeff Geohas, Narendra Godbole, A Golay, SILIVA LAPERTOSA, Jens Gross, Hanne Løvdal Gulseth, F Helland, Hans Olav Høivik, Claire Michael Issa, Eun Seok Kang, Claus Keller, Samir Helmy Assaad Khalil, N H Kim, I J Kim, Leslie J. Klaff, Martin Laimer, Jordan C. Larocque, Samuel Lederman, K-W Lee, W. Reid Litchfield, M B Manning, Ann Mertens, Emily Morawski, Alexander V. Murray, Philip Nicol, Thomas M. O'Connor, Aytekin Oğuz, Sean Wei Xiang Ong, Ali Özdemir, E M Palace, Bryce Palchick, J Pereles-Ortiz, Thomas R. Pieber, Rudolf Prager, Vanessa Preumont, Ernie Riffer, Lucas Rista, Gottfried Rudofsky, RAMAZAN SARI, André Scheen, Bernd Schultes, Ji A Seo, Sara Shelbaya, Kanagaratnam Sivalingam, Christopher Sorli, S Stäuble, Dan Streja, Guy T’Sjoen, Tamer Tetıker, L. Van Gaal, Chris Vercammen, Mark Warren, D. Weinstein, D Weiss, Alexander White, Michael Winnie, Cecilie Wium, Dilek Gogaş Yavuz - The Lancet Diabetes & Endocrinology 2019 被引用: 274

  12. Ten things to know about ten cardiovascular disease risk factors

    著者: , , , , , , , , , , , , , , , , , , , - American Journal of Preventive Cardiology 2021 被引用: 259

  13. Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

    著者: , , , , , , , , - Diabetes Care 2013 被引用: 496

  14. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

    著者: , , , , , , , , , , - Journal of clinical lipidology 2013 被引用: 528

  15. Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023

    著者: , , , , , , , - Obesity Pillars 2023 被引用: 104

  16. Adiposopathy

    著者: - Journal of the American College of Cardiology 2011 被引用: 430

  17. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

    著者: , , , , , , , , , , , - Journal of clinical lipidology 2015 被引用: 785

  18. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

    著者: , - Obesity Pillars 2022 被引用: 128

  19. Role of Bempedoic Acid in Clinical Practice

    著者: , , , , , - Cardiovascular Drugs and Therapy 2021 被引用: 150

  20. Anti-PCSK9 Monotherapy for Hypercholesterolemia

    著者: , , , , , , , , , - Journal of the American College of Cardiology 2014 被引用: 407

  21. Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement

    著者: , , , , , , , , , , , - American Journal of Preventive Cardiology 2021 被引用: 126

  22. Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

    著者: , , , , , , , - New England Journal of Medicine 2010 被引用: 912

  23. Ten things to know about ten cardiovascular disease risk factors – 2022

    著者: , , , , , , , , , , , , , - American Journal of Preventive Cardiology 2022 被引用: 128

  24. Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

    著者: , , , , - Obesity Pillars 2022 被引用: 67